sb 202190 has been researched along with AIDS Dementia Complex in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
AIDS Dementia Complex: A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-Ruiz, O | 1 |
| Navarro, L | 1 |
| Méndez-Díaz, M | 1 |
| Galicia, O | 1 |
| Elder, JH | 1 |
| Sanna, PP | 1 |
| Drucker-Colín, R | 1 |
| Prospéro-García, O | 1 |
1 other study available for sb 202190 and AIDS Dementia Complex
| Article | Year |
|---|---|
Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase.
Topics: AIDS Dementia Complex; Animals; Brain; Butadienes; Drug Interactions; Enzyme Inhibitors; HIV Envelop | 2001 |